1. Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma.
- Author
-
O'Hare Doig RL, Chiha W, Giacci MK, Yates NJ, Bartlett CA, Smith NM, Hodgetts SI, Harvey AR, and Fitzgerald M
- Subjects
- Animals, Calcium Channel Blockers pharmacology, Disease Models, Animal, Female, Imidazoles pharmacology, Macrophages drug effects, Macrophages metabolism, Macrophages pathology, Microglia drug effects, Microglia metabolism, Microglia pathology, Nerve Degeneration drug therapy, Nerve Degeneration etiology, Nerve Degeneration pathology, Nystagmus, Optokinetic drug effects, Nystagmus, Optokinetic physiology, Optic Nerve Injuries complications, Optic Nerve Injuries drug therapy, Optic Nerve Injuries pathology, Oxidative Stress drug effects, Oxidative Stress physiology, Piperazines pharmacology, Purinergic P2X Receptor Antagonists pharmacology, Quinoxalines pharmacology, Random Allocation, Ranvier's Nodes drug effects, Ranvier's Nodes metabolism, Ranvier's Nodes pathology, Rats, Receptors, AMPA antagonists & inhibitors, Calcium Channels metabolism, Nerve Degeneration metabolism, Optic Nerve Injuries metabolism, Receptors, AMPA metabolism, Receptors, Purinergic P2X7 metabolism
- Abstract
Background: Following partial injury to the central nervous system, cells beyond the initial injury site undergo secondary degeneration, exacerbating loss of neurons, compact myelin and function. Changes in Ca
2+ flux are associated with metabolic and structural changes, but it is not yet clear how flux through specific ion channels contributes to the various pathologies. Here, partial optic nerve transection in adult female rats was used to model secondary degeneration. Treatment with combinations of three ion channel inhibitors was used as a tool to investigate which elements of oxidative and structural damage related to long term functional outcomes. The inhibitors employed were the voltage gated Ca2+ channel inhibitor Lomerizine (Lom), the Ca2+ permeable AMPA receptor inhibitor YM872 and the P2X7 receptor inhibitor oxATP., Results: Following partial optic nerve transection, hyper-phosphorylation of Tau and acetylated tubulin immunoreactivity were increased, and Nogo-A immunoreactivity was decreased, indicating that axonal changes occurred acutely. All combinations of ion channel inhibitors reduced hyper-phosphorylation of Tau and increased Nogo-A immunoreactivity at day 3 after injury. However, only Lom/oxATP or all three inhibitors in combination significantly reduced acetylated tubulin immunoreactivity. Most combinations of ion channel inhibitors were effective in restoring the lengths of the paranode and the paranodal gap, indicative of the length of the node of Ranvier, following injury. However, only all three inhibitors in combination restored to normal Ankyrin G length at the node of Ranvier. Similarly, HNE immunoreactivity and loss of oligodendrocyte precursor cells were only limited by treatment with all three ion channel inhibitors in combination., Conclusions: Data indicate that inhibiting any of a range of ion channels preserves certain elements of axon and node structure and limits some oxidative damage following injury, whereas ionic flux through all three channels must be inhibited to prevent lipid peroxidation and preserve Ankyrin G distribution and OPCs.- Published
- 2017
- Full Text
- View/download PDF